Business Wire

BCW Introduces BCW CyberTREE™, A Strategic Model for Cybersecurity Crisis Communications Response and Planning

5.11.2019 21:25:00 EET | Business Wire | Press release

Share

BCW (Burson, Cohn & Wolfe), a leading global communications agency, today announced the launch of BCW CyberTREE™, a strategic model for cybersecurity crisis communications response and planning. Built using BCW’s key learnings from managing and studying myriad high-profile cybersecurity issues and crises, BCW CyberTREE enables clients to create tailored cybersecurity crisis communications strategies based on more than 25 individual factors that influence reputation risk during a cyber event. BCW CyberTREE also provides a battle-tested roadmap to help clients develop cybersecurity crisis communications playbooks or to audit existing plans.

“Cybersecurity threats continue to become more and more sophisticated, however managing cybersecurity reputation risk has not kept pace with the evolution of threats,” said Donna Imperato, Global CEO, BCW. “BCW CyberTREE™ is our firm’s effort to codify and systemize a strategic approach to cybersecurity crisis communications that helps clients mitigate business and reputational damage during and after an attack.”

BCW CyberTREE was developed to help client communication teams quickly and efficiently integrate with their internal Computer Security Incident Response Teams (CSIRTs), which typically also include specialized external legal counsel and forensics consultants. CyberTREE accounts for key legal and regulatory considerations, as well as the inherent challenges of cybersecurity forensics, to help protect corporate reputation and meet stakeholder expectations in an increasingly precarious environment.

BCW CyberTREE is comprised of more than 25 individual factors related to cybersecurity crisis communications and is organized into four domains:

  • Threat considerations are based upon the nature of the threat actor, the exploit (i.e., the network vulnerability and attack mechanism), and potential stakeholder impact based on information accessed.
  • Response considerations, which focus on ensuring the effectiveness of a company’s cybersecurity communications response.
  • Expectations decision points, which ensure alignment between a client’s operational and communications response with media and stakeholder expectations. And,
  • Engagement considerations, which are designed to help BCW guide clients as they plan and execute a strategic, highly coordinated communications response leading up to during, and immediately after a cybersecurity disclosure announcement.

“Stakeholder opinions about how well an organization managed a cyberattack can be as important as the technical recovery itself,” said Michael Estevez, Executive Vice President, Managing Director and Cybersecurity Crisis Team Lead, BCW. “We created CyberTREE to help clients systematically evaluate the reputation risks associated with their specific situation and create a tailored crisis communications strategy to help maintain the trust and confidence of their customers, employees and other key constituencies.”

About BCW

BCW (Burson Cohn & Wolfe), one of the world’s largest full-service global communications agencies, is in the business of moving people on behalf of clients. Founded by the merger of Burson-Marsteller and Cohn & Wolfe, BCW delivers digitally and data-driven creative content and integrated communications programs grounded in earned media and scaled across all channels for clients in the B2B, consumer, corporate, crisis management, CSR, healthcare, public affairs and technology sectors. BCW is a part of WPP (NYSE: WPP), a creative transformation company. For more information, visit www.bcw-global.com.

For more information about BCW CyberTREE contact BCW’s cybersecurity specialty group at cyber@bcw-global.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Catherine Sullivan
212.601.3205
Catherine.Sullivan@bcw-global.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FPT Named an OpenAI Select Partner6.8.2026 03:00:00 EEST | Press release

Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into

U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 01:10:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of ORZEYFUL marks a new chapter for the narcolepsy type 1 community, as we introduce an entirely new class of medicine that will potentially redefine how this disease is managed and howpeople feel on treatment,” said Julie Kim, president and chief executive officer of Takeda. “We are proud to have discovered and developed this orexin treatment innovation and will bring it to adults living with NT1 as quickly as possible.” NT1 is a rare, chronic neurological disease d

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 23:30:00 EEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted

Clinilabs Announces Medical Leadership Appointments5.8.2026 17:05:00 EEST | Press release

Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership, and operational excellence with a track record of execution from first-in-human studies through regulatory

Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 17:00:00 EEST | Press release

Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye